Khalifa Maha Mohamed Mohamed, Said Ahmed, Mortada Ayman, Shehata Hassan
Department of Cardiology, Ain Shams University Hospital, Cairo, Egypt.
J Cardiovasc Echogr. 2020 Apr-Jun;30(2):68-74. doi: 10.4103/jcecho.jcecho_66_19. Epub 2020 Aug 17.
Cardiac resynchronization therapy (CRT) has a morbidity and mortality benefits in moderate to severe heart failure. It reduces mortality and hospitalization and improves cardiac function. It can be used according to the European guidelines in severely depressed left ventricular ejection fraction (i.e., ≤35%) and complete left bundle branch block. However, 30% of patients may show no benefit from CRT therapy. Therefore, prediction of CRT response seems to be an important subject for study in the current researches. We aimed to study the correlation between Surface ECG QRS complex duration (QRS) duration and cardiac output measured by ventricular outflow tract velocity time integral (LVOT VTI) as a predictor of response in patients with CRT implantation.
We studied 100 consecutive patients prospectively with biventricular pacing system. The patients were studied at the pacemaker follow-up clinic. Each patient was subjected to: Full medical history, general and local examination, a 12 lead electrocardiogram and QRS duration in ms was measured. All patients were subjected to a focused transthoracic echocardiographic examination in which a parasternal long axis view was obtained to measure the diameter of the LVOT diameter in mid-systole. The LVOT VTI was measured by pulsed-wave Doppler in the LVOT using a 2-mm sample volume positioned just proximal to the aortic valve in the apical five chamber view.
We found a statistically significant difference between CRT responders and nonresponders as regards age, body surface area (BSA), time since CRT implantation and smoking status ( = 0.018, 0.039, 0.002, <0.001). There was negative significant correlation between QRS duration and LVOT VTI and stroke volume index. The optimal cut off values for optimal response to CRT using receiver operating characteristics curves were 130 ms for postimplant QRS duration and 17.1 cm for LVOT VTI. We also found a significant difference between responders and nonresponders as regard CO. It was higher in responders (5.97 vs. 3.34, < 0.001).
CRT response is more in patients with lower BSA, and without previous history of ischemic heart disease or smoking. There is a significant negative correlation between QRS duration and LVOT VTI.
心脏再同步治疗(CRT)对中重度心力衰竭患者具有降低发病率和死亡率的益处。它可降低死亡率和住院率,并改善心脏功能。根据欧洲指南,对于左心室射血分数严重降低(即≤35%)且完全性左束支传导阻滞的患者可使用该治疗方法。然而,30%的患者可能无法从CRT治疗中获益。因此,预测CRT反应似乎是当前研究中的一个重要课题。我们旨在研究体表心电图QRS波群时限(QRS)与通过心室流出道速度时间积分(LVOT VTI)测量的心输出量之间的相关性,以此作为CRT植入患者反应的预测指标。
我们前瞻性地研究了100例连续接受双心室起搏系统治疗的患者。这些患者在起搏器随访门诊接受研究。每位患者均接受:全面的病史采集、全身和局部检查、一份12导联心电图并测量以毫秒为单位的QRS时限。所有患者均接受一次针对性的经胸超声心动图检查,获取胸骨旁长轴视图以测量收缩中期LVOT直径。使用位于心尖五腔视图中主动脉瓣近端的2毫米样本容积,通过脉冲波多普勒在LVOT中测量LVOT VTI。
我们发现CRT反应者与无反应者在年龄、体表面积(BSA)、CRT植入后的时间以及吸烟状况方面存在统计学显著差异(P = 0.018、0.039、0.002、<0.001)。QRS时限与LVOT VTI及每搏输出量指数之间存在显著负相关。使用受试者工作特征曲线确定的对CRT最佳反应的最佳截断值,植入后QRS时限为130毫秒,LVOT VTI为17.1厘米。我们还发现反应者与无反应者在心输出量方面存在显著差异。反应者的心输出量更高(5.97对3.34,P < 0.001)。
BSA较低、无前驱缺血性心脏病病史或不吸烟的患者对CRT的反应更佳。QRS时限与LVOT VTI之间存在显著负相关。